Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Musumeci

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Pharmaceutics|May 25, 2024
Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted TherapyFrancesca Musumeci, Silvia Schenone
Journal of Medicinal Chemistry|October 27, 2012
Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitorsFrancesca Musumeci, Marco Radi, Chiara Brullo, et al.
Future Medicinal Chemistry|April 26, 2012
An update on dual Src/Abl inhibitorsFrancesca Musumeci, Silvia Schenone, Chiara Brullo, et al.
Expert Opinion on Investigational Drugs|June 19, 2010
Novel dual Src/Abl inhibitors for hematologic and solid malignanciesSilvia Schenone, Chiara Brullo, Francesca Musumeci, et al.
Cancers|November 15, 2018
Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid LeukemiaFrancesca Musumeci, Chiara Greco, Giancarlo Grossi, et al.
Expert Opinion on Therapeutic Patents|September 16, 2015
Analogs, formulations and derivatives of imatinib: a patent reviewFrancesca Musumeci, Silvia Schenone, Giancarlo Grossi, et al.
Expert Opinion on Therapeutic Patents|February 7, 2015
Bcr-Abl tyrosine kinase inhibitors: a patent reviewAndrea Desogus, Silvia Schenone, Chiara Brullo, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of NeuroblastomaFrancesca Musumeci, Annarita Cianciusi, Ilaria D'Agostino, et al.
International Journal of Molecular Sciences|February 10, 2024
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma TreatmentDavide Frumento, Giancarlo Grossi, Marta Falesiedi, et al.
Current Medicinal Chemistry|January 17, 2020
Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsIlaria Giacchello, Francesca Musumeci, Ilaria D'Agostino, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Pharmaceutics|May 25, 2024
Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted TherapyFrancesca Musumeci, Silvia Schenone
Journal of Medicinal Chemistry|October 27, 2012
Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitorsFrancesca Musumeci, Marco Radi, Chiara Brullo, et al.
Future Medicinal Chemistry|April 26, 2012
An update on dual Src/Abl inhibitorsFrancesca Musumeci, Silvia Schenone, Chiara Brullo, et al.
Expert Opinion on Investigational Drugs|June 19, 2010
Novel dual Src/Abl inhibitors for hematologic and solid malignanciesSilvia Schenone, Chiara Brullo, Francesca Musumeci, et al.
Cancers|November 15, 2018
Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid LeukemiaFrancesca Musumeci, Chiara Greco, Giancarlo Grossi, et al.
Expert Opinion on Therapeutic Patents|September 16, 2015
Analogs, formulations and derivatives of imatinib: a patent reviewFrancesca Musumeci, Silvia Schenone, Giancarlo Grossi, et al.
Expert Opinion on Therapeutic Patents|February 7, 2015
Bcr-Abl tyrosine kinase inhibitors: a patent reviewAndrea Desogus, Silvia Schenone, Chiara Brullo, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of NeuroblastomaFrancesca Musumeci, Annarita Cianciusi, Ilaria D'Agostino, et al.
International Journal of Molecular Sciences|February 10, 2024
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma TreatmentDavide Frumento, Giancarlo Grossi, Marta Falesiedi, et al.
Current Medicinal Chemistry|January 17, 2020
Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsIlaria Giacchello, Francesca Musumeci, Ilaria D'Agostino, et al.
Pageof 6